1. Home
  2. FGBI vs CRBP Comparison

FGBI vs CRBP Comparison

Compare FGBI & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Guaranty Bancshares Inc.

FGBI

First Guaranty Bancshares Inc.

HOLD

Current Price

$9.80

Market Cap

151.6M

Sector

Finance

ML Signal

HOLD

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$10.65

Market Cap

147.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FGBI
CRBP
Founded
1934
2009
Country
United States
United States
Employees
346
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
151.6M
147.4M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
FGBI
CRBP
Price
$9.80
$10.65
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$45.60
AVG Volume (30 Days)
11.8K
223.3K
Earning Date
05-11-2026
05-05-2026
Dividend Yield
0.41%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,822,272.00
Revenue This Year
$567.70
N/A
Revenue Next Year
N/A
$100.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
97.62
52 Week Low
$4.31
$6.10
52 Week High
$10.55
$20.56

Technical Indicators

Market Signals
Indicator
FGBI
CRBP
Relative Strength Index (RSI) 63.69 63.28
Support Level $7.79 $7.91
Resistance Level $10.08 $11.64
Average True Range (ATR) 0.35 0.71
MACD 0.06 0.06
Stochastic Oscillator 86.57 85.59

Price Performance

Historical Comparison
FGBI
CRBP

About FGBI First Guaranty Bancshares Inc.

First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana, through several banking facilities. The principal business activity of the company includes attracting deposits and investing it together with funds generated from operations and borrowings insecurities and in lending activities to serve the credit needs of its customer base. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and to a lesser extent, consumer and multifamily loans.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: